News
Shares of Novo Nordisk skidded on Tuesday as the Danish drugmaker reduced its expectations on wildly popular drugs Ozempic ...
Novo Nordisk cut its full-year guidance as U.S. sales continue to be hurt by copycat versions of its blockbuster Wegovy ...
Medical bottles and a syringe are seen with the Novo Nordisk logo displayed on a screen in the background.
Novo Nordisk stock fell after the drugmaker unexpectedly cuts its full-year guidance, citing lower sales expectations for its ...
Novo Nordisk appoints Maziar Mike Doustdar as the new CEO to tackle falling sales and shares amid stiff competition in the ...
Wall Street gains as investors eye US trade talks with China, Fed rate decision and earnings reports
Wall Street chugged mostly higher in premarket trading as Chinese and U.S. officials begin a second day of trade talks.
Explore more
Novo Nordisk has lowered its sales and profit forecasts for the second time this year due to competitive pressures in the ...
Novo Nordisk (NVO) stock falls as the company names a new CEO and cuts outlook citing pressure on obesity drug sales. Eli ...
Novo Nordisk A/S lowered its financial forecast in a surprise update that cited lagging sales of its weight-loss drug Wegovy, as the company fights to regain its leading position in the obesity market ...
Desai believes it's a "good time for fixed income," but wants to see more realistic investor expectations. Generations out there in the past got accustomed to getting just 1% -2.5% for investing in 10 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results